TASHA HUMPHREYS: Open Payments
NPI 1851717953 · EXETER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 63 payments from 8 companies in 2025. Trend: 2023 $1,455 · 2024 $1,561 · 2025 $1,661
Food & beverage: $1,653Education: $8
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 22 | $702 |
| Otsuka America Pharmaceutical, Inc. | 8 | $283 |
| ABBVIE INC. | 13 | $272 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $142 |
| Lundbeck LLC | 1 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: Auvelity, REXULTI, VRAYLAR, CAPLYTA, TRINTELLIX, SPRAVATO, INGREZZA.
Industry payments across NH — which companies pay providers there.
